Creative Planning - SIENNA BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 5 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Creative Planning ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$4,000
-73.3%
17,7620.0%0.00%–
Q2 2019$15,000
-63.4%
17,7620.0%0.00%–
Q1 2019$41,0000.0%17,7620.0%0.00%–
Q4 2018$41,000
-84.4%
17,7620.0%0.00%
-100.0%
Q3 2018$263,000–17,762–0.00%–
 Download
Other shareholders
SIENNA BIOPHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Golden State Wealth Management, LLC 180,552$36,0000.01%
MILLENNIUM MANAGEMENT LLC 122,942$24,0000.00%
CITIGROUP INC 1,739$00.00%
GOLDMAN SACHS GROUP INC 52,553$11,0000.00%
MORGAN STANLEY 101$00.00%
ACADIAN ASSET MANAGEMENT LLC 15,936$3,0000.00%
BANK OF MONTREAL /CAN/ 20$00.00%
BlackRock Inc. 90,036$18,0000.00%
Ballentine Partners, LLC 16,700$3,0000.00%
Citadel Advisors 83,839$17,0000.00%
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders